Lewy body dementia (LBD) affects more than 1 million people in the United States, making it one of the most common forms of dementia after Alzheimer’s disease. Despite those numbers, it remains widely underdiagnosed, and the true prevalence is likely higher than current estimates suggest.
Prevalence by the Numbers
LBD is an umbrella term covering two related conditions: dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD). Both involve abnormal protein deposits in the brain called Lewy bodies, but they differ in which symptoms appear first. In DLB, cognitive decline comes before or alongside movement problems. In PDD, Parkinson’s motor symptoms develop years before dementia sets in.
The combined incidence rate of DLB and PDD is roughly 5.9 per 100,000 person-years, based on population studies. Broken down, DLB accounts for about 3.5 per 100,000 and PDD about 2.5. Both rates climb steeply with age, and the disease typically begins at age 50 or older. Men are diagnosed at roughly twice the rate of women. For DLB specifically, incidence is about 4.8 per 100,000 in men compared to 2.2 in women.
Why It’s Almost Certainly Undercounted
The 1 million figure for the U.S. is probably conservative. LBD is one of the most frequently misdiagnosed dementias, with roughly one in three patients receiving a wrong initial diagnosis, most often Alzheimer’s disease. For people with early-onset DLB, misdiagnosis rates run as high as 50%.
Autopsy studies reveal just how wide the gap is between clinical diagnosis and what’s actually happening in the brain. Over 61% of people whose autopsies confirmed they had both Alzheimer’s and Lewy body pathology were diagnosed during their lifetime as having Alzheimer’s alone. The Lewy body component was simply missed. At more advanced stages of cognitive decline, clinicians missed the concurrent Lewy body disease up to 85% of the time.
This means many people living with LBD, or a mix of LBD and Alzheimer’s, never receive an accurate diagnosis. They may receive treatments designed for Alzheimer’s that don’t address their full clinical picture, and some Alzheimer’s medications can actually worsen certain LBD symptoms.
How LBD Compares to Other Dementias
Alzheimer’s disease dominates the dementia landscape, accounting for 60 to 80% of all cases. LBD is generally considered the second or third most common type, depending on how vascular dementia is classified in a given study. The overlap with Alzheimer’s makes clean comparisons difficult. Between 32% and 54% of people diagnosed clinically with LBD turn out to also have Alzheimer’s pathology at autopsy. The two diseases coexist far more often than most people realize.
Symptoms That Set LBD Apart
LBD can look a lot like Alzheimer’s or Parkinson’s in its early stages, which is a major reason it gets missed. But it has a distinct pattern. The cognitive problems in LBD tend to hit attention, visual perception, and the ability to plan and organize, rather than memory loss being the dominant early feature. Four symptoms in particular distinguish it from other dementias:
- Visual hallucinations that appear early, often before significant memory loss. These are typically vivid and detailed, involving people, animals, or objects.
- Fluctuating cognition, where alertness and thinking ability shift noticeably over hours or days. A person may seem sharp one moment and confused the next.
- Movement problems resembling Parkinson’s disease, including slowness, tremor, rigidity, and difficulty walking.
- REM sleep behavior disorder, where people physically act out their dreams by yelling, punching, kicking, or falling out of bed. This can begin years before other symptoms appear.
The presence of two or more of these features, alongside progressive cognitive decline, points strongly toward LBD. REM sleep behavior disorder is especially telling. If you or a family member has been acting out dreams for years and later develops cognitive or movement problems, that history is an important clue.
Who Is Most at Risk
Age is the strongest risk factor. LBD rarely appears before 50, and incidence rises sharply in the 60s and 70s. Men are affected at roughly double the rate of women, a pattern that holds for both DLB and the Parkinson’s-related form. Having a family member with LBD or Parkinson’s disease may increase risk, though most cases occur without a clear family history.
The combination of being male, over 60, and experiencing REM sleep behavior disorder represents the highest-risk profile. Some research suggests that the majority of older men diagnosed with REM sleep behavior disorder will eventually develop either Parkinson’s disease or LBD over the following decade.
The Diagnosis Gap Matters
Getting an accurate diagnosis changes how LBD is managed. People with LBD can have severe, sometimes dangerous reactions to certain antipsychotic medications that might be prescribed if a doctor thinks they have Alzheimer’s with behavioral symptoms. Knowing it’s LBD also helps families prepare for the specific challenges ahead: the fluctuating alertness, the visual hallucinations that may not require aggressive treatment, and the movement difficulties that affect daily life.
If the symptoms described above sound familiar, particularly the combination of cognitive changes with vivid hallucinations, fluctuating alertness, or a history of acting out dreams, it’s worth seeking evaluation from a neurologist experienced with LBD. A standard Alzheimer’s workup can miss it entirely.